- call +1-201-465-4211
- email sales@mrinsights.biz
Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland.
Scope of the Report:
This report studies the Urinary Tract Infection Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Urinary Tract Infection Treatment market by product type and applications/end industries.
This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing prevalence, the number of UTI increases, and thus, the high demand for drugs. Hence, increasing prevalence of diabetes worldwide is expected to act as a major driver for the global urinary tract infection therapeutics market.
The growing awareness of the controlled usage of antibiotics is one of the latest trends that gaining traction in the market. Antibiotic resistance leads to various other problems such as longer treatment regimens, longer hospitalizations, and increased side effects. This leads to the enormous burden on the healthcare system in terms of using significant economic and human resources.
EMEA is estimated to be the major revenue contributor to the market by 2023. UTIs have been a huge problem in the European Union (EU). Germany has the highest incidence of UTI among the five major EU countries; Germany, France, Italy, Spain, and the UK. The high mortality rate associated with the hospital-acquired UTI and antibiotic resistance to the infectious organisms are huge challenges for the region.
The global Urinary Tract Infection Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Urinary Tract Infection Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson
Novartis
Pfizer
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Gynaecology and Urology Clinics
Drug Store
Retail Pharmacies
Online Drug Stores
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Urinary Tract Infection Treatment Market Overview
1.1 Product Overview and Scope of Urinary Tract Infection Treatment
1.2 Classification of Urinary Tract Infection Treatment by Types
1.2.1 Global Urinary Tract Infection Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Urinary Tract Infection Treatment Revenue Market Share by Types in 2017
1.2.3 Complicated UTI
1.2.4 Recurring Complicated UTI
1.2.5 Uncomplicated UTI
1.2.6 Neurogenic Bladder Infections
1.2.7 Others
1.3 Global Urinary Tract Infection Treatment Market by Application
1.3.1 Global Urinary Tract Infection Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Gynaecology and Urology Clinics
1.3.4 Drug Store
1.3.5 Retail Pharmacies
1.3.6 Online Drug Stores
1.4 Global Urinary Tract Infection Treatment Market by Regions
1.4.1 Global Urinary Tract Infection Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Urinary Tract Infection Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Urinary Tract Infection Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Urinary Tract Infection Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Urinary Tract Infection Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Urinary Tract Infection Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Urinary Tract Infection Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Urinary Tract Infection Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Urinary Tract Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Urinary Tract Infection Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Urinary Tract Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Urinary Tract Infection Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Urinary Tract Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Urinary Tract Infection Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Urinary Tract Infection Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Urinary Tract Infection Treatment Market Competition, by Players
3.1 Global Urinary Tract Infection Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Urinary Tract Infection Treatment Players Market Share
3.2.2 Top 10 Urinary Tract Infection Treatment Players Market Share
3.3 Market Competition Trend
4 Global Urinary Tract Infection Treatment Market Size by Regions
4.1 Global Urinary Tract Infection Treatment Revenue and Market Share by Regions
4.2 North America Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
5 North America Urinary Tract Infection Treatment Revenue by Countries
5.1 North America Urinary Tract Infection Treatment Revenue by Countries (2013-2018)
5.2 USA Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
6 Europe Urinary Tract Infection Treatment Revenue by Countries
6.1 Europe Urinary Tract Infection Treatment Revenue by Countries (2013-2018)
6.2 Germany Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
6.4 France Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Urinary Tract Infection Treatment Revenue by Countries
7.1 Asia-Pacific Urinary Tract Infection Treatment Revenue by Countries (2013-2018)
7.2 China Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
7.5 India Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
8 South America Urinary Tract Infection Treatment Revenue by Countries
8.1 South America Urinary Tract Infection Treatment Revenue by Countries (2013-2018)
8.2 Brazil Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Urinary Tract Infection Treatment by Countries
9.1 Middle East and Africa Urinary Tract Infection Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Urinary Tract Infection Treatment Revenue and Growth Rate (2013-2018)
10 Global Urinary Tract Infection Treatment Market Segment by Type
10.1 Global Urinary Tract Infection Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Urinary Tract Infection Treatment Market Forecast by Type (2018-2023)
10.3 Complicated UTI Revenue Growth Rate (2013-2023)
10.4 Recurring Complicated UTI Revenue Growth Rate (2013-2023)
10.5 Uncomplicated UTI Revenue Growth Rate (2013-2023)
10.6 Neurogenic Bladder Infections Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Urinary Tract Infection Treatment Market Segment by Application
11.1 Global Urinary Tract Infection Treatment Revenue Market Share by Application (2013-2018)
11.2 Urinary Tract Infection Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Gynaecology and Urology Clinics Revenue Growth (2013-2018)
11.5 Drug Store Revenue Growth (2013-2018)
11.6 Retail Pharmacies Revenue Growth (2013-2018)
11.7 Online Drug Stores Revenue Growth (2013-2018)
12 Global Urinary Tract Infection Treatment Market Size Forecast (2018-2023)
12.1 Global Urinary Tract Infection Treatment Market Size Forecast (2018-2023)
12.2 Global Urinary Tract Infection Treatment Market Forecast by Regions (2018-2023)
12.3 North America Urinary Tract Infection Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Urinary Tract Infection Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Urinary Tract Infection Treatment Revenue Market Forecast (2018-2023)
12.6 South America Urinary Tract Infection Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Urinary Tract Infection Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Urinary Tract Infection Treatment Picture
Table Product Specifications of Urinary Tract Infection Treatment
Table Global Urinary Tract Infection Treatment and Revenu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
